Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Drug Metabolism Reviews|February 3, 2018
Targeting the endocannabinoid system as a potential anticancer approachRico Schwarz, Robert Ramer, Burkhard Hinz
Cancers|November 27, 2021
The Endocannabinoid System as a Pharmacological Target for New Cancer TherapiesRobert Ramer, Felix Wittig, Burkhard Hinz
Frontiers in Pharmacology|May 31, 2019
Modulation of the Endocannabinoid System as a Potential Anticancer StrategyRobert Ramer, Rico Schwarz, Burkhard Hinz
Pharmaceutical Research|November 19, 2008
R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathwayKarin Eichele, Robert Ramer, Burkhard Hinz
Biochemical Pharmacology|November 17, 2009
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1Robert Ramer, Jutta Merkord, Helga Rohde, et al.
International Journal of Molecular Sciences|July 2, 2021
Interleukin-1β Induces Tissue Factor Expression in A549 Cells via EGFR-Dependent and -Independent MechanismsTobias Mechelke, Felix Wittig, Robert Ramer, et al.
Biochemical and Biophysical Research Communications|November 1, 2005
Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinasesSusanne Rösch, Robert Ramer, Kay Brune, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2005
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cellsSusanne Rösch, Robert Ramer, Kay Brune, et al.
Biochemical and Biophysical Research Communications|October 12, 2004
R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid raftsBurkhard Hinz, Robert Ramer, Karin Eichele, et al.
Pageof 5